Register entry

CKD Bio Corporation

Registered sites
1
Drug products
12
Live patents
0
Countries
1
Base
South Korea
Authorisation

Registered operations

What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.

Active ingredient (API) manufacture
Sites

Facilities

1
SiteLocationOperationsFEI
CKD Bio CorporationGyeonggi-do 156-04South KoreaActive ingredient (API) manufacture3002806679
Catalogue

Marketed products

12

Showing 12 of 12.

BrandGeneric nameFormCategory
-ACARBOSEPOWDERBULK INGREDIENT
-CLAVULANATE POTASSIUMPOWDERBULK INGREDIENT
-CLAVULANATE POTASSIUMPOWDERDRUG FOR FURTHER PROCESSING
-CLAVULANATE POTASSIUMPOWDERDRUG FOR FURTHER PROCESSING
-CYCLOSPORINEPOWDERBULK INGREDIENT
-DEMECLOCYCLINE HYDROCHLORIDEPOWDERBULK INGREDIENT
-MYCOPHENOLATE MOFETILPOWDERBULK INGREDIENT
-RIFAMPINPOWDERBULK INGREDIENT
-RIFAMYCIN OPOWDERBULK INGREDIENT
-RIFAMYCIN SODIUMPOWDERBULK INGREDIENT
-TacrolimusPOWDERBULK INGREDIENT
-Vancomycin HydrochloridePOWDERBULK INGREDIENT
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.